Quantcast

Latest drug discovery Stories

2014-10-22 20:23:18

LONDON, Oct. 22, 2014 /PRNewswire/ -- Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014 SummaryGlobalData's clinical trial report, "Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the Chemotherapy Induced Peripheral Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chemotherapy Induced Peripheral Neuropathy. It includes an...

2014-10-22 12:29:59

DUBLIN, Oct. 22, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global and Chinese Microplate Reader Industry Report 2014" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The Global and Chinese Microplate Reader Industry Report is a professional and in-depth study on the current state of the global microplate reader industry with a focus on the Chinese situation. The report provides a basic overview of the industry including...

2014-10-21 23:13:16

Lawrence Livermore National Laboratory researchers recently published an article in PLOS ONE detailing the use of supercomputers to link proteins to drug side effects. The research showed their computational model of predicting side effects to be more predictive than current statistical methods in two cases, and the calculations also predicted new potential side effects. Livermore, California (PRWEB) October 21, 2014 New medications created by pharmaceutical companies have helped millions...

2014-10-21 12:32:21

WHITE PLAINS, N.Y., Oct. 21, 2014 /PRNewswire-USNewswire/ -- For the second year, The Leukemia & Lymphoma Society (LLS) will award funding to leading scientists and researchers who show promise in developing new drug therapies through the Screen to Lead Program. The collaborative program aims to support academic laboratories pursuing research directed towards medicinal chemistry and/or drug target screening in blood cancers. Members of a peer review panel select projects for...

2014-10-20 20:25:49

LONDON, Oct. 20, 2014 /PRNewswire/ -- Report DetailsTreatments for nausea and vomiting - explore business trends, R&D, and revenue forecastsWhat's the future of treating nausea and vomiting? For those medicines you get sales predictions, also exploring research and development. Those treatments hold high potential. There you assess results, progress, therapies, and opportunities.Visiongain's new report forecasts those revenues to 2024 at overall world market, submarket, product,...

2014-10-20 08:31:28

ENGLEWOOD, Colo., Oct. 20, 2014 /PRNewswire/ -- Luoxis Diagnostics, Inc., a subsidiary of Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE), today announced that its academic collaborators will present several peer-reviewed posters highlighting the clinical and research potential for its novel RedoxSYS Diagnostic System, a first-in-class platform that measures oxidation-reduction potential (ORP) in the body in response to injury or illness. A poster demonstrating the clinical value of ORP as a...

2014-10-17 23:01:44

DIA in cooperation with SureClinical will host a complimentary webinar "How New Electronic Trial Master File (eTMF) Data Standards Can Enhance Clinical Trial Efficiency and Quality" on October 28 from 11 a.m. to 12:15 p.m. EDT. Washington (PRWEB) October 17, 2014 DIA in cooperation with SureClinical will host a complimentary webinar "How New Electronic Trial Master File (eTMF) Data Standards Can Enhance Clinical Trial Efficiency and Quality" on October 28 from 11 a.m....

2014-10-15 12:32:31

LONDON, Oct. 15. 30, 2014 /PRNewswire/ -- REPORT HIGHLIGHTS The global market for ADC drugs reached $179 million in 2012 and $396 million in 2013. The market should reach $2.8 billion in 2018 with a compound annual growth rate (CAGR) of 48.1%. This report provides:An overview of the global market for ADCs as a part of the pharmaceutical industry that is looking for innovative technologies.Analyses of global market trends, with data from 2012, 2013, and projections of compound annual...

2014-10-14 23:09:20

Selexis has promoted director of European business development, Marco Bocci, PhD, PharmD, to Vice President, European Licensing and Business Development for Europe. Geneva, Switzerland (PRWEB) October 14, 2014 Selexis SA, a serial innovation company with proven technologies for biologic drug discovery and mammalian cell line development, has promoted director of European business development, Marco Bocci, PhD, PharmD, to Vice President, European Licensing and Business Development. Bocci...

2014-10-14 16:25:50

LONDON, Oct. 14, 2014 /PRNewswire/ -- REPORT HIGHLIGHTSThe global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012. This market is expected to grow to $464.5 million in 2013 and $2.2 billion in 2018 with a compound annual growth rate (CAGR) of 36.8% over the five-year period from 2013 to 2018. This report provides:An overview of the global market for signal transduction therapies and inhibitorsAnalyses of global market trends, with...


Word of the Day
ween
  • To think; to imagine; to fancy.
  • To be of opinion; have the notion; think; imagine; suppose.
The word 'ween' comes from Middle English wene, from Old English wēn, wēna ("hope, weening, expectation"), from Proto-Germanic *wēniz, *wēnōn (“hope, expectation”), from Proto-Indo-European *wen- (“to strive, love, want, reach, win”).
Related